Combined Mcl-1 and YAP1/TAZ inhibition for treatment of metastatic uveal melanoma. Glinkina KA, Teunisse AFAS, Gelmi MC, de Vries J, et al. Melanoma Res 2023 Jul 18. doi: 10.1097/CMR.0000000000000911.

Read + Share

Amedeo Smart

Independent Medical Education

Glinkina KA, Teunisse AFAS, Gelmi MC, de Vries J, et al. Combined Mcl-1 and YAP1/TAZ inhibition for treatment of metastatic uveal melanoma. Melanoma Res 2023 Jul 18. doi: 10.1097/CMR.0000000000000911.
PMID: 37467061